1 陈万青,郑荣寿,张思维,等.2003-2007年中国肺癌发病与死亡分析[J].实用肿瘤学杂志,2012,26(1):6-10.
2 Crinò L,Weder W,Van Meerbeeck J,et al.Early stage and locally advanced(non-metastatic)non-small-cell lung cancer:ESMO clinical practice guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2010,21(Suppl 5):v103-v115.
3 Reed E.Platinum-DNA adduct,nucleotide excision repair and platinum based anti-cancer chemotherapy[J].Cancer Treat Rev,1998,24(5):331-344.
4 De Dosso S,Zanellato E,Nucifora M,et al.ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy[J].Cancer Chemother Pharmacol,2013,72(1):159-165.
5 Park KW,Jung ES,Kim DG,et al.ERCC1 can be a prognostic factor in hilar cholangiocarcinoma and extrahepatic bile duct cancer,but not in intrahepatic cholangiocarcinoma[J].Cancer Res Treat,2013,45(1):63-69.
6 Yuanming L,Lineng Z,Baorong S,et al.BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer[J].BMC Cancer,2013,13(5):103-107.
7 Yan D,Wei P,An G,et al.Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer[J].J Cardiothorac Surg,2013,8(6):149-151.
8 Tiseo M,Bordi P,Bortesi B,et al.ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin[J].Br J Cancer,2013,108(8):1695-1703.
9 冷雪峰,冼磊,陈铭伍,等.非小细胞肺癌组织中ERCC1及TUBB3基因mRNA的表达及其临床意义[J].肿瘤预防与治疗,2012,25(1):1-5.
10 王巍炜,李高峰,巫正伟,等.ERCC1表达在Ⅲ期非小细胞肺癌含铂方案新辅助化疗中的意义[J].山东医药,2009,49(52):3-5.
11 Sodja E,Knez L,Kern I,et al.Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy[J].Eur J Cancer,2012,48(18):3378-3385.
12 Han Y,Wang XB,Xiao N,et al.mRNA expression and clinical significance of ERCC1,BRCA1,RRM1,TYMS and TUBB3 in postoperative patients with non-small cell lung cancer[J].Asian Pac J Cancer Prev,2013,14(5):2987-2990.
13 杨春雨,刘炜,蔡莉.人非小细胞肺癌体外抗肿瘤药物敏感性的实验研究[J].实用肿瘤学杂志,2011,25(5):457-460.
14 Ugurel S,Schadendorf D,Pfohler C,et al.In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma:a multicenter phase II trial of the Dermatologic Cooperative Oncology Group[J].Clin Cancer Res,2006,12(18):5454-5463. |